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DBackground: Infants with hypoplastic left heart syndrome (HLHS) are susceptible to pre-Norwood comorbid-
ities (PCs) and complications. This study aimed to describe the effect of PCs on timing and survival of Norwood
palliation (NP).
Methods: A single-center, retrospective review of infants with HLHS who underwent initial NP between 2003
and 2010 was performed. PCs included intact atrial septum,moderate atrioventricular regurgitation (AVVR),
no antenatal diagnosis, mitral stenosis/aortic atresia subtype, genetic abnormality, and prematurity. Complica-
tions included pre-NP mechanical ventilation, inotropic support, infection, arrhythmia, and end-organ injury.
The primary outcome measure was survival after NP.
Results: 113 patients were included with 78 (69%) patients having at least one PC and 61 (78%) of those pa-
tients having at least one complication. Patients with PCs underwent NP later than those without PCs (7 vs 6
days, P ¼ .036) as well as when associated with a complication (8 vs 5 days, P< .001). Patients with PCs
had similar post-Norwood hospital length of stay (P ¼ .116) except when the PC occurred in conjunction
with a complication (28 vs 21 days; P¼ .015). In-hospital mortality post-NP was 10% and interstage mortality
was 15%. On multivariable analysis,  moderate AVVR was associated with increased overall mortality (OR
2.8, 95% CI 1.3-6.2). Age at NP was not associated with mortality (P ¼ .638).
Conclusions: Although PCs are common in infants with HLHS, only  moderate AVVR was associated with
increased mortality in this single-center experience. Older age at NP was not a significant risk factor for inter-
stage mortality. (J Thorac Cardiovasc Surg 2014;147:897-901)Infants born with hypoplastic left heart syndrome (HLHS)
are vulnerable to significant comorbidities and complica-
tions during the preoperative period before Norwood palli-
ation (NP).1,2 These pre-Norwood comorbidities (PCs) and
complications have been implicated in both survival and de-
velopmental outcomes in multiple single-center and multi-
center reports.1,3-8 Most recently, results from the Single
Ventricle Reconstruction trial demonstrated several anatomic
considerations, such as the degree of atrioventricular valve
regurgitation (AVVR) and ascending aorta diameter, and
patient considerations, such as prematurity and chromo-
somal abnormalities, that were associated with increased
post-Norwood morbidity and mortality.7,8 Fortunately,
continued advancement in antenatal diagnosis of HLHS
by fetal echocardiography has helped decrease the
incidence of some PCs and complications.9-11 However,
the survival benefit from antenatal diagnosis remains
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have improved survival in this population.14,15 Nevertheless,
even the most recent reports demonstrate that early post-
Norwood and interstagemortality continue to plague these in-
fants.16,17 The timing ofNP, a potentialmodifiable risk factor,
has been the topic of prior studyandhasyieldedmixed results.
Although several reports have demonstrated decreased
survival in infants undergoing NP at older ages,2,6,14,18
others have reported either no difference in mortality or
even improved survival with older age at NP.1,7,19 Ultimately,
the age at NP is somewhat an institutionally dependent
factor reliant on surgical availability and referral patterns.
The objective of this study was to assess how the pres-
ence of PCs and complications affect early and interstage
mortality in infants with HLHS in a single, tertiary care pe-
diatric cardiac center. Secondarily, we sought to examine
the effect of PCs on the timing of surgery and implications
on mortality.
METHODS
Patient Selection
A retrospective review of the pediatric cardiovascular surgery database
was performed to identify all infants with HLHS who underwent NP at our
institution between January 2003 and December 2010. All infants with
HLHS who underwent NP as their initial surgical procedure during the
study period were reviewed, including those who required atrial septal or
other catheter-based interventions in the pre-Norwood period. Infants
with variants of this condition such as double-outlet right ventricle with mi-
tral atresia as well as patients requiring initial operations other than therdiovascular Surgery c Volume 147, Number 3 897
Abbreviations and Acronyms
AVVR ¼ atrioventricular valvular regurgitation
CI ¼ confidence interval
HLHS ¼ hypoplastic left heart syndrome
IQR ¼ interquartile range
LOS ¼ length of stay
NP ¼ Norwood palliation
OR ¼ odds ratio
PCs ¼ pre-Norwood comorbidities
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DNorwood operation were excluded. Given the study objective, patients with
HLHS who were not palliated surgically were not included. The cohort of
patients was subsequently assigned into 2 groups on the basis of the pres-
ence of PCs.
All available medical records, laboratory and imaging results, and appli-
cable surgical reports were reviewed. We recorded the presence of PCs
(defined below), pre-Norwood complications (defined below), age at NP,
post-Norwood length of stay (LOS), and mortality. Patient data were re-
corded through stage II palliation. The study was approved by the Baylor
College of Medicine Institutional Review Board.
Definitions
PCs included intact atrial septum,  moderate AVVR, the lack of ante-
natal diagnosis, mitral stenosis–aortic atresia HLHS subtype, genetic ab-
normality, and prematurity. Intact atrial septum was defined as the
absence of any atrium-level communication. Genetic anomalies were de-
termined by chromosomal microarray analysis, genetic consult, or pres-
ence of dysmorphisms. Prematurity was defined as gestational age<37
weeks. The patient cohort was divided into the group with 1 PC (PC
group) and the group who had no-PC (no-PC group).
Preoperative complications included mechanical ventilation, inotropic
support, arrhythmia, end-organ damage, and infection. Mechanical ventila-
tion was defined as ventilation for 24 hours that was not associated with
elective intubation for transport. End-organ damage included neurologic
(preoperative seizure or brain injury documented by imaging), hepatic
(defined as elevation of transaminase> twice normal values and either
persistent coagulopathy or hyperbilirubinemia), or renal injury (defined
as pRIFLE I* classification20). Infection was defined as documented pre-
operative bacterial infection based on identified organism or presumptive
infection treated with intravenous antibiotics for 7 days.
Infancy was defined as age<12 months and the pre-Norwood period in-
cluded the time from birth or transfer to our institution to the time of NP.
Our study evaluated both the inpatient and interstage periods between Nor-
wood and stage II palliation. The inpatient period was defined as either the
time from NP to hospital discharge, from NP to stage II if the patient re-
quired continued hospitalization, or from NP to time of death if mortality
occurred before hospital discharge. The interstage period was defined as
the time after hospital discharge after the Norwood procedure but before
stage II palliation.
Data Collection and Statistics
The data were not normally distributed. Descriptive statistics are re-
ported using median and interquartile range for scale variables and propor-
tions for categorical variables. Univariable analysis of categorical variables
was performed by the Pearson c2 or Fisher exact test, whereas continuous
variables were analyzed using the Mann-Whitney U test. Univariable and
multivariable Cox regression analyses were used to determine risk factors*RIFLE ¼ Risk, Injury, Failure, Loss, and End-stage kidney disease.
898 The Journal of Thoracic and Cardiovascular Surgfor mortality and are expressed as hazard ratios and 95% confidence inter-
vals (CIs). Univariable factors found to be associated with mortality with
a P value<.100 were included in the multivariable analysis. Survival func-
tions were estimated using Kaplan-Meier analysis with log rank test of
significance. Two-tailed test of significance was used in all statistical
analyses. Statistics were performed using SPSS version 19.0 (IBM Corp,
Armonk, NY).
RESULTS
Patient Population
Of 117 patients identified with HLHS, 113 patients met
inclusion criteria and were included in the data analysis.
Four patients with HLHS did not undergo initial NP and
were excluded from data analysis. These patients included
1 patient who underwent initial bilateral pulmonary artery
bandingwho died in the interstage period, 2 patients with in-
tact atrial septum who received comfort care, and 1 patient
who underwent hybrid palliation as a bridge to successful
cardiac transplantation owing to coronary artery–left ventri-
cle fistulas.
A total of 78 (69%) patients had at least 1 PC. Patient de-
mographics and frequency of PCs are listed in Table 1.
Among patients with PCs, 36 (46.1%) patients had 1 PC,
36 (46.1%) had 2 PCs, 5 (6.4%) had 3 PCs, and 1 (1.3%)
had 4 PCs. Of the 78 patients with a PC, 61 (78.2%) had
a pre-Norwood complication. Patients with PCs had more
frequent preoperative complications than those without
PCs as demonstrated by higher rates of inotropic support
(57.7% vs 28.6%; P ¼ .004), mechanical ventilation
(44.9% vs 22.9%; P ¼ .026), and infection (11.5% vs
0%; P ¼ .036). There was no significant intergroup differ-
ence in the rate of arrhythmia (1.3% vs 8.6%; P ¼ .053).
The presence of pre-Norwood complications by PC is listed
in Table 2.
Despite similar rates of antenatal diagnosis in nonwhite
versus white patients (62.3% vs 48.3%; P ¼ .138), non-
white patients were more likely to be born outside of our in-
stitution (odds ratio [OR], 3.0; 95% CI, 1.4-6.6). However,
the frequency of PC did not differ between nonwhite versus
white patients (55.1% vs 48.6%; P ¼ .518). With regard to
pre-Norwood complications, patients with no antenatal di-
agnosis were more likely to have a complication than those
with antenatal diagnosis (OR, 8.3; 95% CI, 3.6-19.3). The
use of a modified Blalock-Taussig shunt versus a Sano con-
duit was similar between the PC and no-PC groups (76.9%
vs 88.6%; P ¼ .148).
The overall survival to stage II palliation for the cohort
was 75.2% (85 patients). Among the 28 patients who
died, 11 (9.7%) patients died during the inpatient period
and 17 (15.1%) died during the interstage period. On uni-
variable analysis of PCs, intact atrial septum and  moder-
ate AVVR were associated with increased overall mortality
(Table 3). Likewise, mechanical ventilation before the NP
was found to be associated with increased mortality
(P ¼ .010). On multivariable analysis, only  moderateery c March 2014
TABLE 1. Patient demographics
Demographic Value (n ¼ 113)
Male sex, n (%) 65 (57.5)
Ethnicity, n (%)
Asian 1 (0.9)
African American 13 (11.5)
Hispanic 46 (40.7)
White 53 (46.9)
HLHS subtype, n (%)
MA, AA 57 (50.4)
MA, AS 9 (8.0)
MS, AS 26 (23.0)
MS, AA* 21 (18.6)
Birth weight Z-score, median (IQR) 0.4 (1.0 to 0.0)
No antenatal diagnosis,* n (%) 51 (45.1)
 Moderate AVVR,* n (%) 21 (18.6)
Genetic abnormality,* n (%) 17 (15.0)
Prematurity,* n (%) 13 (11.5)
Intact atrial septum,* n (%) 4 (3.5)
Modified BTS (vs Sano), n (%) 91 (80.5)
HLHS, Hypoplastic left heart syndrome; AA, aortic atresia; MA, mitral atresia; AS,
aortic stenosis; MS, mitral stenosis; IQR, interquartile range; AAVR, atrioventricular
valve regurgitation; BTS, Blalock-Taussig shunt; Sano, Sano conduit. *Demographic
considered as a preoperative comorbidity.
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DAVVR was independently associated with increased mor-
tality in this cohort. Although mechanical ventilation was
associated with increased mortality on univariable analysis,
no preoperative complication was associated with mortality
on multivariable analysis.
The median age at time of NP for the entire cohort was 7
(interquartile range [IQR], 4-8) days, with 64.6% of patients
being7 days of age. Median age at time of NPwas older in
the PC group than in the no-PC group (7 [IQR, 5-9] vs 6
[IQR, 4-7] days; P¼ .036). However, when the lack of ante-
natal diagnosis was excluded as a PC, the presence of any
other PC was not associated with age at NP (P ¼ .422).
Patients with PC who had a pre-Norwood complication
did have a higher median age at time of NP (8 [IQR, 5-12]
vs 5 [IQR, 4-7] days; P<.001). Patient age at NP was unaf-
fected by race (P ¼ .817). When survival after NP was as-
sessed by timing of the Norwood palliation, older age at
palliation (age 7days) was not associated with mortality
when compared with NP at <7 days of age (log rank
P ¼ .638, Figure 1).TABLE 2. Presence of preoperative complication by preoperative comorb
Preoperative co
Complication Moderate AVVR No antenatal diagnosis M
Inotropic support 3.3 (1.2-9.1)* 2.9 (1.3-6.1)*
Mechanical ventilation 3.4 (1.3-9.0)* 2.8 (1.3-6.0)*
Infection 4.1 (0.9-16.8) 4.8 (0.9-24.1)
Arrhythmia 0.8 (0.7-0.9) 0.5 (0.4-0.6)
All data are presented as odds ratio (95% confidence interval). AVVR, Atrioventricular regu
association.
The Journal of Thoracic and CaPostoperatively, patients in the PC group had a median
post-Norwood hospital LOS similar to that of the no-PC
group (P¼ .116) except when the PC occurred in conjunction
with a preoperative complication (28 [IQR, 19-49] days vs 21
[IQR, 14-32] days; P ¼ .015). Continued admission through
to stage II palliation and interstage readmission were not
statistically different between the 2 groups (P ¼ .324 and
P ¼ .084, respectively).DISCUSSION
This retrospective study of 113 infants with HLHS dem-
onstrates that PCs are very common in infants with HLHS
and are associated with a significant delay in the timing of
NP. The effects of timing of NP on patient outcomes have
been the focus of prior investigations, although the evidence
in the literature is mixed. Although older age at time of NP
was initially thought to be associated with better out-
comes,1,19 more recent data have demonstrated either
worse outcomes2,6,14,17,18 or no difference in outcomes
after NP.7 Our study is unique in that we assessed the impact
of PCs both on the timing of NP and on early and interstage
mortality.
PCswere present in>two thirds of the cohort, and>three
quarters of those patients had concomitant pre-Norwood
complications. Among the complications analyzed in this
study, the need for mechanical ventilation and inotropic sup-
port were most common. Prior studies have reported that the
need formechanical ventilation is associatedwith poorer neu-
rodevelopmental outcomes3,5 and increased postoperative
mortality.1 Similar to those findings, we demonstrated a sig-
nificant association betweenmechanical ventilation and over-
all mortality. However, onmultivariable analysis, mechanical
ventilation did not reach statistical significance when placed
in a model with well-established risk factors for mortality.
Unlike previous reports,4,8,21 our study failed to find an
association between prematurity or genetic anomalies and
mortality, although this may be due to small sample size.
Neither the presence of PCs, PCs with complications, nor
delayed NP (independent of PCs) was associated with di-
minished inpatient or interstage survival on multivariable
analysis. This suggests that NP can be successfully achieved
in an infant with a complicated pre-Norwood course if the
patient’s condition can be adequately stabilized. Althoughidity
morbidity
S-AA subtype Prematurity Genetic abnormality IAS
1.2 (0.5-3.1) 0.9 (0.3-2.8) 0.9 (0.3-2.6) 1.1 (1.0-1.2)
1.0 (0.4-2.7) 0.7 (0.2-2.4) 0.9 (0.3-2.6) 1.1 (1.0-1.2)
1.3 (0.2-6.6) 2.4 (0.4-13.1) 0.8 (0.8-0.9) 1.0 (0.9-1.0)
1.5 (0.1-15.0) 0.9 (0.8-0.9) 1.9 (0.2-19.8) 1.0 (0.9-1.0)
rgitation;MS-AA, mitral stenosis–aortic atresia; IAS, intact atrial septum. *Significant
rdiovascular Surgery c Volume 147, Number 3 899
TABLE 3. Risk factors for overall mortality before stage II palliation
Risk factor
Univariable Multivariable
HR 95% CI HR 95% CI
Female sex 1.4 0.7-2.9 — —
Nonwhite ethnicity 1.7 0.8-3.7 — —
Pre-Norwood comorbidity
HLHS subtype
MA, AA Reference — —
MA, AS 1.3 0.5-3.5 — —
MS, AS 1.4 0.3-5.8 — —
MS, AA 0.5 0.1-1.9 — —
No antenatal diagnosis 0.8 0.4-1.6 — —
Intact atrial septum 3.6 1.1-11.9 2.1 0.6-7.5
Moderate-Severe AVVR 3.6 1.7-7.7 2.8 1.3-6.2
Genetic disorder 1.7 0.7-4.3 — —
Prematurity 0.6 0.1-2.3 — —
Pre-Norwood complication
Mechanical ventilation 2.7 1.2-5.9 2.0 0.9-4.6
Infection 1.6 0.5-5.4 — —
Inotrope requirement 1.2 0.6-2.5 — —
End organ damage 1.1 0.5-2.6 — —
Arrhythmia 1.0 0.1-6.8 — —
HR, Hazard ratio; CI, confidence interval; HLHS, hypoplastic left heart syndrome;
MA, mitral atresia; AA, aortic atresia; AS, aortic stenosis; MS, mitral stenosis;
AAVR, atrioventricular valve regurgitation.
FIGURE 1. Kaplan-Meier survival function by the timing of Norwood
palliation at<7 and 7 days of age.
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Dour findings suggest that infants may undergo NP safely
at an age of 7 days, it is important to recognize that
65% of patients underwent NP by day 7 after birth in our
cohort and that 95% underwent NP by 10 days after birth.
Ultimately, established risk factors, such as intact atrial sep-
tum or severe AVVR,2,7,8,22,23 are more likely to be stronger
determinants of post-Norwood mortality as suggested by
our data.
Advances in fetal echocardiography have improved the
ability and availability to diagnose HLHS prenatally. Al-
though several studies have shown little to no survival ben-
efit with antenatal diagnosis, there are other data that
indicate that antenatal diagnosismayminimize the risk of pre-
operative morbidity and improve long-term outcomes.10,11,13
In the current study, infants who received an antenatal
diagnosis of HLHS were less likely to experience multiple
preoperative comorbidities. Moreover, they underwent NP
considerably earlier than those without antenatal diagnosis.
These differences in outcomes are most likely explained by
heightened perinatal awareness, including parental prenatal
counseling, delivery within a pediatric surgical center, or
prompt transfer to a surgical center. Yet, despite this height-
ened awareness, we found that antenatal diagnosis was not
associated with significant improvement in postoperative
mortality. It should be noted, however, that mortality may
be too coarse an end point to detect the impact of delayed
NP on long-term single ventricle physiology, the health of
the pulmonary vascular bed, ventricular performance, and
even on neurodevelopment.900 The Journal of Thoracic and Cardiovascular SurgThe presence of a PC significantly prolonged time to NP
and lengthened postoperative hospital LOS when occurring
in conjunction with a pre-Norwood complication. These
findings are important in consideration of health care use
and efforts to reduce medical costs. Recent reports have
demonstrated increasing health care costs in infants under-
going staged palliation for HLHS.24 Given the economic
burden that prolonged hospitalization places on the health
care system and the families of these affected infants, our
findings suggest that attention should be focused on maxi-
mizing antenatal diagnosis to better identify PCs whenever
possible, reduce complication rates, and implement orga-
nized discharge planning early on in their hospital course.
Additionally, although the precise cause of delayed timing
could not be ascertained owing to study design, it is con-
ceivable that a longer pre-Norwood course may lead to
a higher risk of complications. Thus, completing the initial
palliative surgery in a prompt manner may play a role in
both reducing likelihood of pre-Norwood complications
and LOS after the Norwood procedure.
We found that nonwhite ethnicity was associated with
a higher incidence of birth outside of our tertiary, surgical
referral center, which mirrors other reports demonstrating
racial disparities among children with congenital heart dis-
ease.25 Interestingly, our study showed that rates of antena-
tal diagnosis were similar between races and that the
presence of PCs was not affected by race. It is conceivable,
however, that a difference in need for hospital transfer
versus direct access to a surgical center may translate into
increased risk for the development of pre-Norwood compli-
cations in the neonatal period, although this was not seen in
our study.Limitations
Our current study is limited by its single-center, retro-
spective design of a relatively small number of patients. Al-
though all available data were used in all statistical
analyses, negative associations described in this studyery c March 2014
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Dmay be a result of a lack of statistical power. Therefore, it is
difficult to exclude the possibility of a type II error, and fur-
ther study with a greater number of patients would be re-
quired to establish negative associations. The potential for
selection bias exists as a function of the study design.
Only infants who underwent NP as their initial surgical pro-
cedure were included, and some infants who were small for
gestational age or premature may have been excluded.C
HCONCLUSIONS
PCs are common in infants with HLHS and are associ-
ated with pre-Norwood complications. When occurring
concomitantly with a pre-Norwood complication, PCs are
significantly associated with delayed NP and longer post-
Norwood hospital LOS. Prenatal diagnosis appears to be
beneficial in minimizing the risk of pre-Norwood complica-
tions and expediting the timing of NP. Mortality was
affected by the presence ofmoderate AVVR in this cohort
and not the presence of any pre-Norwood complication or
older age at NP. With successful antenatal diagnosis and
medical management of infants with PCs, post-Norwood
outcomes are likely to parallel those without preoperative
complications.References
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